VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
University of Texas Southwestern Medical Center
University of Texas Southwestern Medical Center
Children's Hospital of Philadelphia
St. Jude Children's Research Hospital
Milton S. Hershey Medical Center
National Institutes of Health Clinical Center (CC)
University of Florida
Eli Lilly and Company
Dana-Farber Cancer Institute
GlaxoSmithKline
Memorial Sloan Kettering Cancer Center
University Hospital Tuebingen
Sun Yat-sen University
Hutchmed
University of Birmingham
University Hospital, Basel, Switzerland
Bayer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eisai Inc.
Bristol-Myers Squibb
Eisai Inc.
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Boehringer Ingelheim
Celgene
N.N. Petrov National Medical Research Center of Oncology
National University Hospital, Singapore
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Novartis
European Organisation for Research and Treatment of Cancer - EORTC
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital